Skip to content
The merger between BerGenBio ASA and Oncoinvent ASA was completed 29 October 2025, and the Combined company was renamed to Oncoinvent. This webpage contains historical documents related to BerGenBio before the merger.
Oncoinvent ASA
Recent news
Oncoinvent ASA: New share capital registered
Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ovarian Cancer in Gynecologic Oncology
Oncoinvent ASA: Notification of trade – primary insider/close associate
Oncoinvent ASA: Resolution to increase the share capital in connection with settlement of underwriting fee
Oncoinvent ASA: Minutes from Extraordinary General Meeting
Oncoinvent ASA: Notification of trade – primary insider/close associate
Oncoinvent ASA: Final results of the rights issue
Oncoinvent ASA: Preliminary results of the rights issue
Oncoinvent ASA: Last day of the subscription period in the rights issue
